ly 117018 has been researched along with ng-nitroarginine methyl ester in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dube, G; Laher, I; Rahimian, R; van Breemen, C | 1 |
| Dolphin, PJ; Dubé, PJ; McKendrick, JD; Radomski, MW; Russell, JC | 1 |
2 other study(ies) available for ly 117018 and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Estrogen and selective estrogen receptor modulator LY117018 enhance release of nitric oxide in rat aorta.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Calcium; Dose-Response Relationship, Drug; Estradiol; Estrogens; Female; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Pyrrolidines; Rats; Rats, Sprague-Dawley; Thiophenes | 1997 |
Effects of LY117018 and the estrogen analogue, 17alpha-ethinylestradiol, on vascular reactivity, platelet aggregation, and lipid metabolism in the insulin-resistant JCR:LA-cp male rat: role of nitric oxide.
Topics: Animals; Aorta; Blood Pressure; Body Weight; Cholesterol Esters; Eating; Enzyme Inhibitors; Estradiol Congeners; Estrogen Antagonists; Ethinyl Estradiol; Insulin Resistance; Lipid Metabolism; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Aggregation; Pyrrolidines; Rats; Thiophenes; Triglycerides; Vasoconstriction | 2001 |